ABL1 |
P00519
|
ABL proto-oncogene 1, non-receptor tyrosine kinase
|
Kinase
|
1.00 |
0.432 |
0.923 |
AKT1 |
P31749
|
AKT serine/threonine kinase 1
|
Kinase
|
0.98 |
0.311 |
0.962 |
ASXL1 |
Q8IXJ9
|
ASXL transcriptional regulator 1
|
|
1.3E-14 |
0.482 |
0.808 |
ATN1 |
P54259
|
atrophin 1
|
|
1.00 |
0.409 |
0.885 |
BCR |
P11274
|
BCR activator of RhoGEF and GTPase
|
Enzyme modulator
|
0.99 |
0.431 |
0.885 |
CALR |
P27797
|
calreticulin
|
Calcium-binding protein
|
0.89 |
0.413 |
0.923 |
CBL |
P22681
|
Cbl proto-oncogene
|
Enzyme
|
6.1E-04 |
0.527 |
0.769 |
CD34 |
P28906
|
CD34 molecule
|
|
5.0E-06 |
0.368 |
0.808 |
CDKN2A |
P42771 Q8N726
|
cyclin dependent kinase inhibitor 2A
|
|
0.39 |
0.300 |
0.885 |
CDKN2B |
P42772
|
cyclin dependent kinase inhibitor 2B
|
|
7.3E-03 |
0.417 |
0.769 |
CXCR4 |
P61073
|
C-X-C motif chemokine receptor 4
|
G-protein coupled receptor
|
1.8E-02 |
0.362 |
0.923 |
DNMT1 |
P26358
|
DNA methyltransferase 1
|
Epigenetic regulator
|
1.00 |
0.406 |
0.885 |
DNMT3A |
Q9Y6K1
|
DNA methyltransferase 3 alpha
|
|
7.4E-39 |
0.445 |
0.846 |
EBI3 |
Q14213
|
Epstein-Barr virus induced 3
|
Signaling
|
0.11 |
0.474 |
0.808 |
EPO |
P01588
|
erythropoietin
|
|
1.1E-02 |
0.381 |
0.885 |
ETV6 |
P41212
|
ETS variant transcription factor 6
|
Transcription factor
|
0.97 |
0.477 |
0.731 |
EZH2 |
Q15910
|
enhancer of zeste 2 polycomb repressive complex 2 subunit
|
Epigenetic regulator
|
1.00 |
0.376 |
0.885 |
FGFR1 |
P11362
|
fibroblast growth factor receptor 1
|
Kinase
|
1.00 |
0.362 |
0.885 |
FIP1L1 |
Q6UN15
|
factor interacting with PAPOLA and CPSF1
|
|
0.79 |
0.575 |
0.577 |
FLT3 |
P36888
|
fms related receptor tyrosine kinase 3
|
Kinase
|
0.61 |
0.462 |
0.654 |
H3P10 |
|
H3 histone pseudogene 10
|
|
|
0.350 |
0.846 |
H3P9 |
|
H3 histone pseudogene 9
|
|
|
0.505 |
0.731 |
IL18R1 |
Q13478
|
interleukin 18 receptor 1
|
Receptor
|
8.6E-06 |
0.473 |
0.808 |
IL1B |
P01584
|
interleukin 1 beta
|
|
0.13 |
0.276 |
0.962 |
IL1RN |
P18510
|
interleukin 1 receptor antagonist
|
|
3.1E-02 |
0.373 |
0.923 |